Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapyDouglas B. Johnson, Justin M. Balko, Mónica V. Estrada et al.|Nature Communications|2016Cited by 580
Tumor-specific MHC-II expression drives a unique pattern of resistance to immunotherapy via LAG-3/FCRL6 engagementDouglas B. Johnson, Justin M. Balko, Jeffrey A. Sosman et al.|JCI Insight|2018Cited by 162
MEK activation modulates glycolysis and supports suppressive myeloid cells in TNBCDerek A. Franklin, Justin M. Balko, Joe T. Sharick et al.|JCI Insight|2020Cited by 50
Cryogenic Etching of Silicon: An Alternative Method for Fabrication of Vertical Microcantilever Master MoldsKweku A. Addae‐Mensah, John P. Wikswo, Scott T. Retterer et al.|Journal of Microelectromechanical Systems|2010Cited by 20
Biomolecular Signatures of Diabetic Wound Healing by Structural Mass SpectrometryKelly M. Hines, John A. McLean, Samir Ashfaq et al.|Analytical Chemistry|2013Cited by 18